Enhancing Prostate Cancer Staging: Association of 68Ga-PSMA PET/CT Imaging with Histopathological Grading in Treatment-Naive Patients
68Ga-PSMA PET/CT demonstrated high sensitivity in detecting high-risk prostate cancer, particularly in patients with GS > 7 or PSA levels ≥ 10 ng/mL. The findings suggest that this imaging modality may be less effective for the staging of patients with lower GS or PSA values, that is, low-risk PCa. Further prospective studies are necessary to validate these results.
Authors
- Jan Adamowicz (ORCID: https://orcid.org/0000-0003-2479-7133)
- Krzysztof Kaczmarek (ORCID: https://orcid.org/0000-0001-8806-7792)
- Piotr Zorga (ORCID: https://orcid.org/0000-0002-9962-3747)
- Piotr Petrasz
- Michał Cezary Czarnogórski (ORCID: https://orcid.org/0000-0003-3186-6088)
- Katarzyna Brzeźniakiewicz‐Janus (ORCID: https://orcid.org/0000-0002-4143-5778)
- Marcin Gałęski
- Paweł Szponar
- Tomasz Drewa (ORCID: https://orcid.org/0000-0001-5347-4136)
- Oleksii Pisotskyi
Institutions
- Nicolaus Copernicus University (PL)
- Wyższa Szkoła Biznesu w Gorzowie Wielkopolskim (PL)
- Collegium Medicum in Bydgoszcz (PL)
- University of Zielona Góra (PL)
Publication Details
- Journal
- Cancers
- Published
- 2024-10-18
- DOI
- https://doi.org/10.3390/cancers16203526
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42